These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17546694)

  • 1. Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population.
    Chuang WC; Sarkodie F; Brown CJ; Owusu-Ofori S; Brown J; Li C; Navarrete C; Klenerman P; Allain JP
    J Med Virol; 2007 Jun; 79(6):724-33. PubMed ID: 17546694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.
    Candotti D; Temple J; Sarkodie F; Allain JP
    J Virol; 2003 Jul; 77(14):7914-23. PubMed ID: 12829831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus replication in Caucasian HIV controllers.
    Ruiz-Mateos E; Machmach K; Romero-Sanchez MC; Ferrando-Martinez S; Viciana P; Del Val M; Muñoz-Fernandez MA; Genebat M; Leal M;
    J Viral Hepat; 2011 Jul; 18(7):e350-7. PubMed ID: 21692947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
    Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
    Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
    Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes.
    Nii-Trebi NI; Brown CA; Osei YD; Ampofo WK; Nyarko AK
    BMC Infect Dis; 2019 Jun; 19(1):533. PubMed ID: 31208352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
    Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
    Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.
    Tsai SL; Chen PJ; Hwang LH; Kao JH; Huang JH; Chang TH; Chen DS
    J Hepatol; 1994 Sep; 21(3):403-11. PubMed ID: 7530738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
    Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
    J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
    Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
    Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
    Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J;
    Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
    Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
    Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
    Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    Bokharaei-Salim F; Keyvani H; Esghaei M; Zare-Karizi S; Dermenaki-Farahani SS; Hesami-Zadeh K; Fakhim S
    J Med Virol; 2016 Nov; 88(11):1960-6. PubMed ID: 27463051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
    Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
    J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.